February 7-8, 2018 NVAC Meeting

February 7, 2018 - February 8, 2018

The Great Hall, Humphrey Building
200 Independence Avenue, S.W.
Washington, DC 20201

Agenda

Day 1 – Wednesday, February 7th

TimeAgenda ItemPresenter(s)
9:00 – 9:10 a.m.Welcome, Roll Call, and Rules of EngagementDr. Angela Shen, Designated Federal Officer
9:10 – 9:20 a.m.Opening RemarksDr. Don Wright, Acting Assistant Secretary for Health
9:20 – 9:30 a.m.NVPO UpdateDr. Melinda Wharton, Acting Director, NVPO
9:30 – 9:45 a.m.NVAC Chair UpdateDr. Kimberly Thompson, NVAC Chair
9:45 a.m. – 12:30 p.m.Update on Implementation of HPV Recommendations 
9:45 – 10:00 a.m.Overview: HPV Report RecommendationsDr. Nathaniel Smith, NVAC Voting Member
10:00 – 10:15 a.m.Surveillance Update and Overview of CDC ActivitiesDr. Melinda Wharton, CDC
10:15 – 10:30 a.m.NCI Cancer Control ResearchDr. Sarah Kobrin, NCI
10:30 – 10:45 a.m.NCI’s Research Efforts on Reduced-dose HPV VaccinationDr. John Schiller, NCI (on behalf of Dr. Aimée Kreimer, NCI)
10:45 – 11:00 a.m.HPV Case Study: Denver HealthDr. Anna-Lisa Farmar, Denver Health
11:00 – 11:15 a.m.Break 
11:15 – 11:30 a.m.HPV Vaccination Initiatives at the American Cancer SocietyDr. Debbie Saslow, ACS (presentation via phone)
11:30 a.m. – 12:00 p.m.Round Robin: Partner Updates and Implementation Activities 
  Dr. Anne Edwards, AAP
Dr. Pamela G. Rockwell, AAFP
Dr. Jennie Yoost, ACOG
Dr. Cynthia Rand, APA
Ms. Margaret Farrell, NCI, on behalf of CCCNP
Ms. Gretchen Forsell, AHEC
Dr. Amy Middleman, SAHM
Dr. Ruth Lipman, ADA
Dr. Frances Kim, AAPHD (presentation via phone)
12:00 – 12:30 p.m.Discussion 
12:30 – 1:45 p.m.Lunch 
1:45 – 2:30 p.m.Vaccine Innovation: Updates 
1:45 – 1:55 p.m.Incentivizing the Development of Vaccines: Recommendations from the Presidential Advisory Council on Combating Antibiotic-Resistant BacteriaDr. Timothy Cooke, NVAC Voting Member and PACCARB Vaccine Working Group Member
1:55 – 2:10 p.m.Zika Vaccine Development UpdateDr. Robert Johnson, ASPR-BARDA
2:10 – 2:30 p.m.Discussion 
2:30 – 3:15 p.m.Vaccine Innovation: Next Generation Influenza Vaccine Development 
2:30 – 2:40 p.m.Next Generational Influenza Vaccine DevelopmentDr. Robert Johnson, ASPR-BARDA
2:40 – 2:50 p.m.NIAID Universal Influenza Vaccine PortfolioDr. Teresa Hauguel, NIH
2:50 – 3:15 p.m.Discussion 
3:15 – 3:30 p.m.Break 
3:30 – 5:15 p.m.Vaccine Innovation: Vaccine Adjuvants 
3:30 – 3:45 p.m.Overview of Progress and Landscape in AdjuvantsDr. Karin Bok, NVPO
3:45 – 4:05 p.m.The NIAID Vaccine Adjuvant Program: A Pipeline of Novel Compounds to Safely Enhance Vaccine EfficacyDr. Wolfgang Leitner, NIH
4:05 – 4:25 p.m.Precision Vaccines: Using Adjuvants to Bring Precision Medicine to VaccinologyDr. Ofer Levy, Boston Children’s Hospital
4:25 – 4:45 p.m.Vaccine AdjuvantsDr. Leonard Friedland, NVAC Member/BIO
4:45 – 5:15 p.m.Discussion 
5:15 – 5:30 p.m.Public Comment 
5:30 p.m.Day 1 Wrap Up and AdjournDr. Kimberly Thompson, NVAC Chair

Day 2 – Thursday, February 8th

TimeAgenda ItemPresenter(s)
9:00 – 9:05 a.m.Welcome and Wrap Up from Previous DayDr. Kimberly Thompson, NVAC Chair
9:05 – 10:15 a.m.NVAC Liaison and Ex Officio Updates 
9:05 – 9:15 a.m.Agency Highlight: 2017-2018 Flu Season UpdateMs. Lynnette Brammer, CDC (presentation via phone)
9:15 – 9:45 a.m.Ex Officio Member UpdatesAHRQ, ASPR-BARDA, CDC, CMS, DoD, FDA, HRSA-BPHC, HRSA-DICP, IHS, NIH, USAID, USDA, VA
9:45 – 10:15 a.m.Liaison Member UpdatesACCV, ACIP, AHIP, AIM, AIRA, APhA, ASTHO, NACCHO, PHAC, PAHO, VRBPAC
10:15 – 10:45 a.m.National Adult and Influenza Immunization Summit and National Immunization Conference 
10:15 – 10:30 a.m.Working Group Updates, 2018 NAIIS, and NICDr. Litjen Tan, IAC, on Behalf of NAIIS Co-Chairs (CDC, IAC, and NVPO)
10:30 – 10:45 a.m.Discussion 
10:45 – 11:00 a.m.Break 
11:00 a.m. – 12:15 p.m.Disparities in Adult Immunizations 
11:00 – 11:15 a.m.Disparities in Adult Immunization – 2016 NHISDr. Ram Koppaka, CDC
11:15 – 11:30 a.m.Understanding Dynamics Underlying Racial Disparities in Influenza VaccinationDr. Sandra Crouse Quinn, University of Maryland
11:30 – 11:45 a.m.CMS Quality Innovation Network-Quality Improvement Organizations (QIN-QIOs) Improving Medicare Beneficiary Immunizations Among Disparate PopulationsDr. Shiree Southerland, CMS
11:45 – 12:15 p.m.Discussion 
12:15 – 12:30 p.m.Public Comment 
12:30 p.m.Closing Remarks and AdjournDr. Kimberly Thompson, NVAC Chair

Abbreviations

AAP — American Academy of Pediatrics

AAFP — American Academy of Family Physicians

ACCV — Advisory Commission on Childhood Vaccines

ACIP — Advisory Committee on Immunization Practices

ACOG — American College of Obstetricians and Gynecologists

ADA — American Dental Association

AHEC — Area Health Education Center

AHIP — America’s Health Insurance Plans

AHRQ — Agency for Healthcare Research and Quality

AIM — Association of Immunization Managers

AIRA — American Immunization Registry Association

APA — American Pediatric Association

APhA— American Pharmacists Association

ASPR — Assistant Secretary for Preparedness and Response

ASTHO — Association of State and Territorial Health Officials

BARDA — Biomedical Advanced Research and Development Authority

CCCNP — Comprehensive Cancer Control National Partnership

CDC — Centers for Disease Control and Prevention

CMS — Centers for Medicare and Medicaid Services

DoD — Department of Defense

FDA — Food and Drug Administration

HRSA-BPHC — Health Resources and Services Administration - Bureau of Primary Healthcare

HRSA-DICP — Health Resources and Services Administration - Division of Injury Compensation

IHS — Indian Health Service

NACCHO — National Association of County and City Health Officials

NCI — National Cancer Institute

NIAID — National Institute of Allergy and Infectious Diseases

NIH — National Institutes of Health

PACCARB — Presidential Advisory Council on Combating Antibiotic Resistant Bacteria

PAHO — Pan American Health Organization

PHAC — Public Health Agency of Canada

SAHM — Society for Adolescent Health and Medicine

USAID — U.S. Agency for International Development

USDA — U.S. Department of Agriculture

VA — Department of Veterans Affairs

VRBPAC — Vaccines and Related Biological Products Advisory Committee

View the Meeting Recording

Certified Minutes

Content last reviewed